Department of Neurology

Department Home >

  • Base >
  • You are here
Department of Neurology

Neuro-Oncology

 

Current Neuro-Oncology Trials
A Phase II Trial of Talampanel in Conjunction with Radiation Therapy with Concurrent and Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Mulitforme

PI: Myrna R. Rosenfield, MD, PhD
A Phase II Trial of Radiation plus Temozolomide followed by adjuvant Temozolomide and Poly-ICLC in Patients with Newly Diagnosed Glioblastoma Multiforme

PI: Myrna R. Rosenfield, MD, PhD
A Safety Run-In/Randomized Phase II Trial of EMD 121974 in Conjunction with Concomitant and Adjuvant Temozlomide with Radiation Therapy in PAtients with Newly Diagnosed Glioblastoma Multiforme

PI: Myrna R. Rosenfield, MD, PhD
A Phase I Evaluation of the Safety of PS-341 in the Treatment of Recurrent Gliomas

PI: Myrna R. Rosenfield, MD, PhD
A Phase I Trial of BAY 43-9006 for Patients with Recurrent or Progressive Malignant Gliomas

PI: Josep Dalmau, MD, PhD
A Phase I/II Trial of BMS-247550 for Treatment of PAtients with Recurrent Malignant Gliomas

PI: Josep Dalmau, MD, PhD
A Study of Autoimmune Responses in Disorders of the Nervous System

PI: Josep Dalmau, MD, PhD
Paraneoplastic Disorders of the CNS: Autoantigen Profiling

PI: Josep Dalmau, MD, PhD
Evaluation of T-Cell Immunity in Patients with Antibody-associated Paraneoplastic Neurologic Disorders

PI: Josep Dalmau, MD, PhD
Immunity to Brain Ma Proteins: A Remote Effect of Cancers

PI: Josep Dalmau, MD, PhD

Top ^